Aggression
1
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Temple TherapeuticsPsychotherapy
Kairos PharmaAggression
EppendorfEgo-depletion
Human BioSciencesFriend to Friend
Clinical Trials (4)
Total enrollment: 5,558 patients across 4 trials
Cognitive Behavioral Aggression Treatment
Start: May 2010Est. completion: Feb 2016120 patients
Phase 2Completed
The Added Value of an Internet-based Intervention for Treatment of Forensic Psychiatric Outpatients
Start: Feb 2023Est. completion: Dec 2023128 patients
N/AUnknown
The Influence of Ego-depletion on Implicit Aggression and Cognitive Performance
Start: Feb 2021Est. completion: May 202160 patients
N/AUnknown
NIH R01 Friend to Friend With Coaching
Start: Nov 2019Est. completion: Jun 20255,250 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.